Superparamagnetic Iron Oxide Nanoparticles-Complexed Cationic Amylose for In Vivo Magnetic Resonance Imaging Tracking of Transplanted Stem Cells in Stroke

Bingling Lin, Jun Zhang, Liejing Lu, Jiaji Mao, Minghui Cao, Xuhong Mao, Fang Zhang, Xiaohui Duan, Chushan Zheng, Liming Zhang, Jun ShenNanomaterials 2017 · DOI

TL;DR

This paper introduces a novel nanocomplex, ASP-SPIONs, made from cationic amylose and superparamagnetic iron oxide nanoparticles (SPIONs), for effectively labeling mesenchymal stem cells (MSCs). This allows for reliable in vivo tracking of these transplanted cells using MRI for up to six weeks in a stroke model, demonstrating their survival and therapeutic benefit without compromising cell function.

What Problem Does This Paper Address?

Cell-based therapies, particularly using mesenchymal stem cells (MSCs), hold great promise for treating conditions like ischemic stroke. However, to truly understand and optimize these therapies, it's crucial to track the fate of transplanted cells in the body. Magnetic Resonance Imaging (MRI) is an ideal non-invasive tool for this, but effectively labeling stem cells for MRI has been a challenge. Standard superparamagnetic iron oxide nanoparticles (SPIONs) are often not efficiently taken up by non-phagocytic stem cells. Existing methods to improve uptake, like using transfection agents, can have saturation effects, require long incubation times, and potentially harm the cells or their biological behavior. This paper aims to develop a safer, more efficient, and faster method for labeling MSCs for in vivo MRI tracking in the context of stroke treatment.

Methods

The researchers developed a novel nanocomplex called ASP-SPIONs. This involved:

  • Cationic Amylose Synthesis: Hydrophobic amylose was modified by grafting spermine (a biogenic amine) onto its hydroxyl groups using a CDI activation method. This made the amylose cationic and hydrophilic, improving its interaction with cell membranes.
  • One-Pot Synthesis of ASP-SPIONs: The cationic amylose (ASP) was then complexed with ultrasmall superparamagnetic iron oxide nanoparticles (SPIONs) in a single-step, high-temperature aqueous solution process. This method avoided the need for additional surface modification.
  • Characterization: The synthesized nanoparticles were characterized using various techniques, including Fourier Transform Infrared (FT-IR) spectroscopy, 1H Nuclear Magnetic Resonance (NMR) spectroscopy, Thermogravimetric (TG) analysis, X-ray Diffraction (XRD), Transmission Electron Microscopy (TEM), dynamic light scattering (DLS) for size and zeta potential, and atomic absorption spectrometry (AAS) for iron content. Magnetic properties were assessed using a vibrating sample magnetometer.
  • Cell Labeling and In Vitro Evaluation: Green fluorescent protein (GFP)-labeled MSCs were used. The optimal conditions for labeling were determined by varying incubation time and SPION concentration, assessing cell viability, apoptosis, intracellular reactive oxygen species (ROS) levels, mitochondrial transmembrane potential, and multilineage differentiation capacity (osteogenic, adipogenic, chondrogenic). Prussian blue staining and TEM were used to assess intracellular distribution and labeling efficiency.
  • In Vivo MRI Tracking: Labeled MSCs were injected into the striatum of rats with experimentally induced cerebral ischemic stroke. MRI was performed at various time points (1-6 weeks) to track the distribution and migration of the labeled cells.
  • Therapeutic Efficacy Assessment: Infarct volume was measured using MRI, and functional recovery was assessed using modified neurological severity scores (mNSS).
  • Histology: At 6 weeks post-transplantation, brains were analyzed using Prussian blue staining and immunofluorescence to confirm the presence and location of labeled cells and assess their differentiation status.

Datasets

Not discussed in the paper. The study relies on experimental data generated from cell cultures and animal models.

Key Insights and Ideas

  • Cationic Amylose as a Smart Carrier: Modifying amylose with spermine creates a cationic and hydrophilic carrier that effectively bridges SPIONs to stem cell membranes, facilitating efficient cellular uptake. This is a clever use of a natural, biodegradable polymer.
  • High Labeling Efficiency with Low SPION Concentration and Short Incubation: The ASP-SPIONs achieved high labeling efficiency with a significantly lower SPION concentration (30 µg/mL) and a much shorter incubation time (1 hour) compared to many existing methods. This is crucial for clinical translation.
  • Preservation of MSC Functionality: A major finding is that labeling MSCs with ASP-SPIONs did not negatively impact their viability, apoptosis rate, ROS levels, mitochondrial function, or their ability to differentiate into various cell types. This is critical for the therapeutic potential of the labeled cells.
  • Long-Term In Vivo Tracking: The study successfully demonstrated the ability to track labeled MSCs in vivo for up to 6 weeks post-transplantation in a stroke model, confirming their survival and retention at the injection site.
  • Therapeutic Benefit Maintained: The transplanted MSCs, whether labeled or unlabeled, showed a similar therapeutic effect in improving functional recovery and reducing infarct volume compared to control groups, indicating that the labeling process did not diminish their therapeutic potential.
  • Enhanced MRI Contrast: The ASP-SPIONs exhibited a significantly higher r2 relaxivity (14-fold) compared to native SPIONs, making them more effective MRI contrast agents.

Key Results

  • Labeling Efficiency: Nearly 100% of MSCs were labeled with ASP-SPIONs, with an average iron content of 2.68 pg per cell under optimal conditions (30 µg/mL iron concentration, 1-hour incubation).
  • Cell Viability: Cell viability remained above 90% within 48 hours post-labeling.
  • In Vivo Tracking: Labeled cells were reliably tracked via MRI as hypointense signals in the striatum for up to 6 weeks.
  • Therapeutic Effect: Both labeled and unlabeled MSCs showed improved functional recovery (lower mNSS scores) compared to PBS controls, with no significant difference between labeled and unlabeled MSC groups.
  • Histology: At 6 weeks, iron-containing cells (ASP-SPION labeled MSCs) were observed at the injection site, and surviving GFP-positive MSCs were detected, with some showing signs of phagocytosis by macrophages but no significant differentiation into neurons or astrocytes.

Limitations and Future Work

  • Overestimation of Cell Mass: The authors acknowledge that in vivo MRI tracking of stem cells, while effective for verifying biodistribution, might overestimate the true size of viable stem cell mass due to the presence of SPIONs in dead cells, released contrast agents, or phagocytosed particles by macrophages.
  • Limited Differentiation: While MSCs retained their multilineage differentiation potential in vitro, in vivo histological analysis showed limited differentiation into neurons or astrocytes, suggesting that a large number of cells might be needed for significant structural repair in the context of stroke.
  • Future Directions: The paper suggests that the ASP-SPIONs, with their inherent structural features and the ability to be modified with specific ligands, have great potential for developing theranostic nanoplatforms. This could involve integrating therapeutic agents or targeting molecules for more advanced applications in regenerative medicine. Further studies could explore the long-term fate and functional integration of these labeled cells in more detail.

Summary updated

Abstract

Cell-based therapy with mesenchymal stem cells (MSCs) is a promising strategy for acute ischemic stroke. In vivo tracking of therapeutic stem cells with magnetic resonance imaging (MRI) is imperative for better understanding cellular survival and migrational dynamics over time. In this study, we develop a novel biocompatible nanocomplex (ASP-SPIONs) based on cationic amylose, by introducing spermine and the image label, ultrasmall superparamagnetic iron oxide nanoparticles (SPIONs), to label MSCs. The capacity, efficiency, and cytotoxicity of the nanocomplex in transferring SPIONs into green fluorescence protein-modified MSCs were tested; and the performance of in vivo MRI tracking of the transplanted cells in acute ischemic stroke was determined. The results demonstrated that the new class of SPIONs-complexed nanoparticles based on biodegradable amylose can serve as a highly effective and safe carrier to transfer magnetic label into stem cells. A reliable tracking of transplanted stem cells in stroke was achieved by MRI up to 6 weeks, with the desirable therapeutic benefit of stem cells on stroke retained. With the advantages of a relatively low SPIONs concentration and a short labeling period, the biocompatible complex of cationic amylose with SPIONs is highly translatable for clinical application. It holds great promise in efficient, rapid, and safe labeling of stem cells for subsequent cellular MRI tracking in regenerative medicine.
BibTeX
@inproceedings{lin2017superparamagnetic,
  author = {Bingling Lin and Jun Zhang and Liejing Lu and Jiaji Mao and Minghui Cao and Xuhong Mao and Fang Zhang and Xiaohui Duan and Chushan Zheng and Liming Zhang and Jun Shen},
  title = {{Superparamagnetic Iron Oxide Nanoparticles-Complexed Cationic Amylose for In Vivo Magnetic Resonance Imaging Tracking of Transplanted Stem Cells in Stroke}},
  booktitle = {Nanomaterials},
  year = {2017},
  doi = {10.3390/nano7050107},
}
Figure